Natixis’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.1M Buy
74,117
+25,422
+52% +$12.8M 0.13% 110
2025
Q4
$22.7M Sell
48,695
-2,858
-6% -$1.33M 0.08% 185
2025
Q3
$22M Sell
51,553
-4,719
-8% -$1.83M 0.1% 177
2025
Q2
$21.6M Sell
56,272
-2,514
-4% -$906K 0.1% 140
2025
Q1
$20.3M Sell
58,786
-69,800
-54% -$22.4M 0.11% 148
2024
Q4
$38.6M Buy
128,586
+43,628
+51% +$15.2M 0.24% 77
2024
Q3
$34.5M Buy
84,958
+11,997
+16% +$4.39M 0.19% 88
2024
Q2
$23.4M Sell
72,961
-30,103
-29% -$9.78M 0.13% 124
2024
Q1
$34.4M Sell
103,064
-54,243
-34% -$16.6M 0.18% 100
2023
Q4
$42.6M Buy
157,307
+106
+0.1% +$26.2K 0.31% 75
2023
Q3
$38.7M Buy
157,201
+65,522
+71% +$17.9M 0.3% 72
2023
Q2
$27.8M Buy
91,679
+26,001
+40% +$7.23M 0.23% 98
2023
Q1
$17.3M Sell
65,678
-68,580
-51% -$17.4M 0.16% 133
2022
Q4
$32.2M Buy
134,258
+48,901
+57% +$11M 0.18% 125
2022
Q3
$15.9M Buy
85,357
+18,951
+29% +$3.78M 0.07% 201
2022
Q2
$11.2M Sell
66,406
-32,026
-33% -$6.88M 0.04% 274
2022
Q1
$24.7M Buy
98,432
+59,795
+155% +$15M 0.09% 223
2021
Q4
$9.93M Sell
38,637
-7,660
-17% -$1.87M 0.03% 399
2021
Q3
$11.2M Buy
46,297
+21,635
+88% +$5.29M 0.04% 344
2021
Q2
$5.1M Buy
24,662
+16,069
+187% +$3.28M 0.02% 378
2021
Q1
$1.62M Sell
8,593
-229,198
-96% -$40.4M 0.01% 743
2020
Q4
$39.1M Buy
237,791
+42,709
+22% +$6.24M 0.14% 150
2020
Q3
$24.3M Sell
195,082
-51,587
-21% -$6.39M 0.18% 124
2020
Q2
$23.9M Buy
246,669
+89,785
+57% +$9.33M 0.19% 105
2020
Q1
$14.1M Buy
+156,884
New +$20.3M 0.11% 170
2019
Q4
Sell
-267,908
Closed -$32.3M 883
2019
Q3
$32.3M Buy
267,908
+225,167
+527% +$29.1M 0.21% 109
2019
Q2
$5.78M Sell
42,741
-454,467
-91% -$57.5M 0.04% 301
2019
Q1
$64M Buy
497,208
+296,168
+147% +$39.8M 0.4% 51
2018
Q4
$25M Buy
201,040
+50,767
+34% +$6.81M 0.21% 124
2018
Q3
$20.9M Sell
150,273
-107,832
-42% -$13.4M 0.12% 176
2018
Q2
$26.5M Buy
258,105
+48,212
+23% +$4.88M 0.14% 156
2018
Q1
$20.4M Buy
+209,893
New +$20.4M 0.13% 175
2017
Q4
Sell
-5,954
Closed -$474K 973
2017
Q3
$474K Sell
5,954
-104,053
-95% -$8.37M ﹤0.01% 707
2017
Q2
$9.59M Buy
+110,007
New +$9.31M 0.11% 180
2017
Q1
Sell
-260,754
Closed -$19.3M 971
2016
Q4
$19.3M Buy
+260,754
New +$19.5M 0.2% 128
2016
Q3
Sell
-119,406
Closed -$9.2M 545
2016
Q2
$9.2M Buy
+119,406
New +$9.43M 0.17% 127
2015
Q3
Sell
-4,371
Closed -$397K 342
2015
Q2
$397K Sell
4,371
-8,414
-66% -$674K 0.01% 276
2015
Q1
$962K Buy
+12,785
New +$918K 0.01% 237

Other funds holding HCA

Natixis's HCA Position: Q1 2026 in Review

Natixis increased its HCA Healthcare (HCA) stake by 52% in Q1 2026, buying an estimated $12.8M and bringing the position to 74,117 shares worth $35.1M. The position accounts for 0.13% of the portfolio, ranked #110.

Natixis first reported a position in HCA in Q1 2015 and has held it in 38 quarters since. The position peaked at $64M in Q1 2019. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Natixis held 74,117 shares of HCA Healthcare worth $35.1M as of Q1 2026.
  • Natixis bought 25,422 HCA Healthcare shares in Q1 2026, an estimated $12.8M.
  • HCA Healthcare made up 0.13% of Natixis's portfolio in Q1 2026, its #110 holding.
  • Natixis first reported a position in HCA Healthcare in Q1 2015 and has held it in 38 quarters since.
  • Natixis's HCA Healthcare position peaked at $64M in Q1 2019.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.